Vemurafenib-induced DRESS/DIHS resulting in spontaneous melanoma regression: an immunological reaction shedding new light on melanoma treatment?

Cristina Olteanu; Alon Scope; Yael Steinberg-Silman; Michael Ziv; Neil H. Shear; Roni Dodiuk-Gad; Gal Markel

doi:10.1111/ijd.14852

Vemurafenib-induced DRESS/DIHS resulting in spontaneous melanoma regression: an immunological reaction shedding new light on melanoma treatment?

Cristina Olteanu, Alon Scope, Yael Steinberg-Silman, Michael Ziv, Neil H. Shear, Roni Dodiuk-Gad, Gal Markel

Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e139-e141
Journal	International Journal of Dermatology
Volume	59
Issue number	5
DOIs	https://doi.org/10.1111/ijd.14852
State	Published - 1 May 2020

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ijd.14852

Cite this

@article{815311d9bcff456cbd9f8874331d6a01,

title = "Vemurafenib-induced DRESS/DIHS resulting in spontaneous melanoma regression: an immunological reaction shedding new light on melanoma treatment?",

author = "Cristina Olteanu and Alon Scope and Yael Steinberg-Silman and Michael Ziv and Shear, {Neil H.} and Roni Dodiuk-Gad and Gal Markel",

note = "Funding Information: source: Dr. Gal Markel has the following supports that did not play any role in this manuscript: Advisory: MSD, BMS, Novartis, Biond biologics. Honoraria: MSD, BMS, Novartis, Roche, Medison. Research grants: Novartis, H&S Ventures. IP: Famewave, 4c biomed. Stocks/options: Famewave, 4c biomed, Biond biologics.",

year = "2020",

month = may,

day = "1",

doi = "10.1111/ijd.14852",

language = "אנגלית",

volume = "59",

pages = "e139--e141",

number = "5",

}

TY - JOUR

T1 - Vemurafenib-induced DRESS/DIHS resulting in spontaneous melanoma regression

T2 - an immunological reaction shedding new light on melanoma treatment?

AU - Olteanu, Cristina

AU - Scope, Alon

AU - Steinberg-Silman, Yael

AU - Ziv, Michael

AU - Shear, Neil H.

AU - Dodiuk-Gad, Roni

AU - Markel, Gal

N1 - Funding Information: source: Dr. Gal Markel has the following supports that did not play any role in this manuscript: Advisory: MSD, BMS, Novartis, Biond biologics. Honoraria: MSD, BMS, Novartis, Roche, Medison. Research grants: Novartis, H&S Ventures. IP: Famewave, 4c biomed. Stocks/options: Famewave, 4c biomed, Biond biologics.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85082185807&partnerID=8YFLogxK

U2 - 10.1111/ijd.14852

DO - 10.1111/ijd.14852

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

AN - SCOPUS:85082185807

SN - 0011-9059

VL - 59

SP - e139-e141

JO - International Journal of Dermatology

JF - International Journal of Dermatology

IS - 5

ER -

Vemurafenib-induced DRESS/DIHS resulting in spontaneous melanoma regression: an immunological reaction shedding new light on melanoma treatment?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this